Fig. 5.
Plasma levodopa levels for sustained- (slow-) release oral levodopa/carbidopa (a) versus continuous intraduodenal infusion of LCIG (b) in each of 12 patients with advanced PD. In each graph, the solid black curve with solid black circles for its data points displays the mean for all curves (data adapted from Nyholm et al. 2003)